Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluticasone propionate: topical or systemic effects?

W C Howland1

  • 1Healthquest Research, Austin, Texas 78759, USA.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
Same author

Survey of the extent and nature of care for adults and older adults by allergy/immunology practitioners.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2000
Same author

An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.

The Journal of allergy and clinical immunology·1999
Same author

A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.

The Journal of family practice·1998
Same author

Measuring quality of life in children with rhinoconjunctivitis.

The Journal of allergy and clinical immunology·1998
Same author

A one-week dose-ranging study of inhaled salmeterol in children with asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma·1997
Same journal

GWAS of Second-Generation Antihistamine Use: Locus Specificity and Highlighted Signalling Pathways.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Basophil Activation Test Provides Additional Diagnostic Value Beyond Ara h 2-Specific IgE Testing in Peanut Allergic Adults.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Characterisation of Allergen Profiles in Commercial Egg Products to Inform Oral Immunotherapy Strategies in Egg Allergy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Allergic Diseases and Risk of Incident Autoimmune Diseases: Phenotype-Specific Patterns and Multimorbidity Effects in a Nationwide Cohort.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Determinants of Total and Inhaled Allergen-Specific Immunoglobulin E in the Middle-Aged and Elderly Population.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same journal

Rhinitis-Related Healthcare Utilization in Colombian Adults, 2015-2024.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
See all related articles

Fluticasone propionate aqueous nasal spray (FPANS) effectively treats allergic rhinitis through direct nasal effects, not systemic absorption. Long-term use showed no significant adverse systemic effects, confirming its safety profile for seasonal and perennial allergic rhinitis.

Area of Science:

  • Allergy and Immunology
  • Pharmacology
  • Otolaryngology

Background:

  • Intranasal corticosteroids (INCS) are effective for allergic rhinitis, but concerns exist regarding potential systemic effects.
  • Fluticasone propionate (FP) is a potent INCS available as an aqueous nasal spray (FPANS).
  • The mechanism of FPANS efficacy (topical vs. systemic) and its long-term safety profile require elucidation.

Purpose of the Study:

  • To compare the efficacy of FPANS with oral FP in patients with seasonal allergic rhinitis.
  • To assess the potential systemic effects of long-term FPANS use in patients with perennial rhinitis.

Main Methods:

  • A 2-week randomized trial compared FPANS (200 mcg/day) with oral FP (5 mg or 10 mg/day) or placebo for seasonal allergic rhinitis.
  • A separate 1-year placebo-controlled study evaluated systemic safety of FPANS (200 mcg/day) in perennial rhinitis patients.

Related Experiment Videos

Main Results:

  • FPANS demonstrated significantly greater improvement in nasal symptoms (obstruction, rhinorrhea, sneezing, itching) compared to oral FP.
  • Long-term FPANS use did not result in significant adverse effects on bone mineral density, bone turnover markers, ocular health (cataracts, glaucoma), or HPA axis function.

Conclusions:

  • The therapeutic efficacy of FPANS in allergic rhinitis is primarily due to direct topical effects on the nasal mucosa.
  • FPANS exhibits a favorable safety profile with minimal risk of systemic adverse effects, even with prolonged use.